HCC IN PATIENTS WITH HCV CIRRHOSIS AND SUSTAINED VIROLOGICAL RESPONSE WITH INTERFERON AND RIBAVIRIN THERAPY- A META-ANALYSIS

被引:0
|
作者
Jaganmohan, Sathya [1 ,2 ]
Guturu, Praveen [1 ]
Malhotra, Advitya [2 ]
Sood, Gagan K. [1 ,2 ]
机构
[1] UTMB, Galveston, TX USA
[2] Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1440
引用
收藏
页码:948A / 948A
页数:1
相关论文
共 50 条
  • [31] Favorable Outcomes of Chinese HCV-Related Cirrhotic Patients with Sustained Virological Response after Pegylated Interferon Plus Ribavirin Treatment
    Zhang, Geng-lin
    Chen, You-ming
    Zhang, Ting
    Cai, Qing-xian
    Zhang, Xiao-hong
    Zhao, Zhi-xing
    Lin, Chao-shuang
    Gao, Zhi-liang
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [32] Impact of anemia and zidovudine use on sustained virological response in a trial of pegylated interferon plus ribavirin in HIV/HCV-coinfected patients
    Nunez, M.
    Romero, M.
    Ocampo, A.
    Aguirrebengoa, K.
    Cervantes, M.
    Pascual, A.
    Echevarria, S.
    Asensi, V.
    Barreiro, P.
    Garcia-Samaniego, J.
    Soriano, V.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S224 - S224
  • [33] Long-term follow-up of HCV patients with sustained virological response after treatment with pegylated interferon plus ribavirin
    Yuan-Ji Ma
    Ling-Yao Du
    Li-Bo Yan
    Juan Liao
    Xing Cheng
    Wu-Wei Xie
    Hong Tang
    Hepatobiliary & Pancreatic Diseases International, 2021, 20 (02) : 137 - 141
  • [34] Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study
    Kovari, Helen
    Russmann, Stefan
    Ledergerber, Bruno
    Mueller, Daniel
    Rotger, Margalida
    Velli, Pablo
    Cavassini, Matthias
    Ambrosioni, Juan
    Bregenzer, Andrea
    Stoeckle, Marcel
    Bernasconi, Enos
    Rauch, Andri
    Speck, Roberto F.
    PLOS ONE, 2015, 10 (07):
  • [35] Long-term follow-up of HCV patients with sustained virological response after treatment with pegylated interferon plus ribavirin
    Ma, Yuan-Ji
    Du, Ling-Yao
    Yan, Li-Bo
    Liao, Juan
    Cheng, Xing
    Xie, Wu-Wei
    Tang, Hong
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2021, 20 (02) : 137 - 141
  • [36] Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients
    Merchante, Nicolas
    de los Santos-Gil, Ignacio
    Merino, Dolores
    Gonzalez-Serrano, Mercedes
    Mira, Jose A.
    Sanz-Sanz, Jesus
    Fernandez-Fuertes, Elisa
    Ruiz-Morales, Josefa
    del Valle, Jose
    Macias, Juan
    Moro, Antonio
    Pineda, Juan A.
    JOURNAL OF HEPATOLOGY, 2009, 50 (04) : 684 - 692
  • [37] Ribavirin plasma concentrations and virological response to peginterferon plus ribavirin therapy in HCV-HIV coinfected patients previously treated with standard interferon combined or not with ribavirin
    Breilh, D.
    Djabarouti, S.
    Trimoulet, P.
    Dupon, M.
    Ragnaud, J. M.
    Chene, G.
    Saux, M. C.
    Neau, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 45 - 45
  • [38] The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon
    Marucco, D. Aguilar
    de Requena, D. Gonzalez
    Bonora, S.
    Tettoni, C.
    Bonasso, M.
    De Blasi, T.
    D'Avolio, A.
    Sciandra, M.
    Siccardi, M.
    Baietto, L.
    Trentini, L.
    Sinicco, A.
    Cariti, G.
    Di Perri, G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) : 919 - 924
  • [39] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Paci, M.
    Lorefice, E.
    Gianni, E.
    Renzo, S.
    Capanni, M.
    Forte, P.
    Milani, S.
    Surrenti, C.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113
  • [40] Analysis of sustained virological response to pegylated interferon & ribavirin treatment in compensated cirrhosis due to hepatitis C virus, genotype 3 infection
    Subhan, Amna
    Jafri, Wasim
    Mumtaz, Khalid
    Hamid, Saeed S.
    Abid, Shahab
    Shah, Hasnain
    Jafri, Nida
    Yakoob, Javed
    Ahmed, Zubair
    GASTROENTEROLOGY, 2008, 134 (04) : A832 - A832